Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern

BACKGROUND: Recent in-vitro data have shown that the activity of monoclonal antibodies (mAbs) targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) varies according to the variant of concern (VOC). No studies have compared the clinical efficacy of different mAbs against Omicron VOC....

Descripción completa

Detalles Bibliográficos
Autores principales: Mazzaferri, Fulvia, Mirandola, Massimo, Savoldi, Alessia, De Nardo, Pasquale, Morra, Matteo, Tebon, Maela, Armellini, Maddalena, De Luca, Giulia, Calandrino, Lucrezia, Sasset, Lolita, D'Elia, Denise, Sozio, Emanuela, Danese, Elisa, Gibellini, Davide, Monne, Isabella, Scroccaro, Giovanna, Magrini, Nicola, Cattelan, Annamaria, Tascini, Carlo, Tacconelli, Evelina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681201/
https://www.ncbi.nlm.nih.gov/pubmed/36413383
http://dx.doi.org/10.7554/eLife.79639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681201/
https://www.ncbi.nlm.nih.gov/pubmed/36413383
http://dx.doi.org/10.7554/eLife.79639

Ejemplares similares